Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention) — ASAP

Thyroiditis, Autoimmune Clinical Trial

Official title:
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Potential Effects of the Dietary Supplement Anatabloc on Antithyroid Autoantibodies and Thyroid Function in Autoimmune Thyroiditis

Status Completed

Clinical Trial Summary

This is a study to evaluate the safety, tolerability, and potential effects of Anatabloc dietary supplementation on antithyroid autoantibodies, thyroid structure, and thyroid function in subjects with autoimmune thyroiditis.

Clinical Trial Description

This is a 5-visit, 12-week, double-blind, randomized, placebo-controlled, parallel-group study. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01551498
Study type	Interventional
Source	Rock Creek Pharmaceuticals, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	March 2012
Completion date	February 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04952012` - The Effect of Thyroid Antibodies on Female Reproductive Function and Pregnancy Outcomes
Not yet recruiting	`NCT05578456` - Effect of Prednisone and Aspirin on IVF-ET Outcome Among Patients With Thyroid Autoimmunity	Phase 4
Completed	`NCT05581147` - Thyroid Function and Structure IN Klinefelter Syndrome
Active, not recruiting	`NCT03103776` - Involvement of Polyomaviruses in the Pathogenesis of Autoimmune Thyroiditis and Goitrigenesis.	N/A